KIMBERLY SWIGERT: Open Payments
NPI 1639265002 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 50 payments from 20 companies in 2025. Trend: 2023 $1,574 · 2024 $3,035 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 5 | $215 |
| Sumitomo Pharma America, Inc. | 12 | $176 |
| Medtronic, Inc. | 3 | $173 |
| Janssen Biotech, Inc. | 6 | $172 |
| Dendreon Pharmaceuticals LLC | 3 | $70 |
| 180 Medical, Inc. | 2 | $55 |
| Procept Biorobotics Corporation | 2 | $48 |
| ACCORD HEALTHCARE, INC. | 2 | $43 |
| UROGEN PHARMA, INC. | 1 | $41 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
Products named: XIAFLEX, GEMTESA, INTERSTIM, ERLEADA, PROVENGE, RYBREVANT, AVEED, ALTAVIVA.
Industry payments across IN — which companies pay providers there.
